Community Practice Connections: 16th Annual International Congress on the Future of Breast Cancer
WebcastFaculty
OVERVIEW
Community Practice Connections: 16th Annual International Congress on the Future of Breast Cancer is organized by Physicians Education Resource, LLC (PER) and will be held during Sep 29, 2017 - Sep 29, 2018.
The target audience for this medical event is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of breast cancer may also participate. This CME Conference has been approved for a maximum of 2 AMA PRA Category 1 Credits.
Overview :
This Conference serves as an update on advances in the breast cancer field, with a focus on the clinical implications of breast cancer genetic and phenotypic subtyping. Novel agents, strategies, and improved regimens are changing the future of breast cancer therapy, and these advances and their clinical impact are highlighted throughout the program. Current controversies in the field are also addressed and new data presented, along with information about how to optimally individualize breast cancer therapy. This activity provides a unique opportunity for medical, surgical, and radiation oncologists and other healthcare professionals to increase knowledge, apply new data to practice, and, ultimately, improve patient outcomes.
Learning Objectives :
At the conclusion of this activity, you should be better prepared to:
• Determine testing strategies that can be utilized to facilitate the diagnosis, ability to stratify risk, and identification of predictive markers in the care of patients with breast cancer
• Apply personalized treatment planning to manage patients with breast cancer based on information obtained from testing strategies
• Delineate approaches that apply local therapies, such as surgical and radiation therapies, to manage patients with breast cancer
• Describe key evidence concerning the use of evolving strategies for the care of patients with breast cancer
• Place recent clinical trial findings in the context of evolving treatment paradigms in the field of breast cancer management
• Identify patients who may benefit from inclusion in a clinical trial evaluating investigational approaches in the setting of breast cancer
Additional details will be posted as soon as they are available.
The target audience for this medical event is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of breast cancer may also participate. This CME Conference has been approved for a maximum of 2 AMA PRA Category 1 Credits.
Overview :
This Conference serves as an update on advances in the breast cancer field, with a focus on the clinical implications of breast cancer genetic and phenotypic subtyping. Novel agents, strategies, and improved regimens are changing the future of breast cancer therapy, and these advances and their clinical impact are highlighted throughout the program. Current controversies in the field are also addressed and new data presented, along with information about how to optimally individualize breast cancer therapy. This activity provides a unique opportunity for medical, surgical, and radiation oncologists and other healthcare professionals to increase knowledge, apply new data to practice, and, ultimately, improve patient outcomes.
Learning Objectives :
At the conclusion of this activity, you should be better prepared to:
• Determine testing strategies that can be utilized to facilitate the diagnosis, ability to stratify risk, and identification of predictive markers in the care of patients with breast cancer
• Apply personalized treatment planning to manage patients with breast cancer based on information obtained from testing strategies
• Delineate approaches that apply local therapies, such as surgical and radiation therapies, to manage patients with breast cancer
• Describe key evidence concerning the use of evolving strategies for the care of patients with breast cancer
• Place recent clinical trial findings in the context of evolving treatment paradigms in the field of breast cancer management
• Identify patients who may benefit from inclusion in a clinical trial evaluating investigational approaches in the setting of breast cancer
Additional details will be posted as soon as they are available.
SPECIALITIES
Oncology
Quick Links